Αποτελέσματα Αναζήτησης
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal, multi-center, observational study. The overall goal of ADNI is to validate biomarkers for Alzheimer’s disease (AD) clinical trials.
- About
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a...
- News & Publications
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a...
- HELP / FAQ
Documentation. Study Documents page if you’re looking for...
- About
22 Ιουλ 2015 · ! 2 PROTOCOL SYNOPSIS Title Alzheimer’s Disease Neuroimaging Initiative 2 (ADNI2) Primary Objective The major goals of ADNI2 are to: 1. Determine the relationships among clinical, imaging, genetic, and biochemical biomarker characteristics of the entire spectrum of Alzheimer’s Disease (AD), as the pathology evolves from normal
Documentation. Study Documents page if you’re looking for study schedules or documents. Background & Rationale page if you’re looking for details about study cohorts. Study Design page if you’re looking for an overview of ADNI and its phases. ADNI3 page if you’re looking for updates on ADNI3.
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer’s disease (AD).
The Worldwide Alzheimer's Disease Neuroimaging Initiative (WW-ADNI) is a collaborative effort to investigate imaging and biofluid markers that can inform Alzheimer's disease treatment...
26 Φεβ 2008 · The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a longitudinal multisite observational study of healthy elders, mild cognitive impairment (MCI), and Alzheimer's disease.
Introduction: The Alzheimer's Disease Neuroimaging Initiative (ADNI) has accumulated 15 years of clinical, neuroimaging, cognitive, biofluid biomarker and genetic data, and biofluid samples...